Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Regitnig

Showing results (61-70 of 89) with videos related to

Pageof 9
Sort By:
Frontiers in Psychology|August 8, 2022
Resilience and Protection of Health Care and Research Laboratory Workers During the SARS-CoV-2 Pandemic: Analysis and Case Study From an Austrian High Security LaboratoryMartina Loibner, Paul Barach, Stella Wolfgruber, et al.
Pathology Oncology Research : POR|April 10, 2017
Is Regression after Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer Different in Sentinel and Non-sentinel Nodes?Gábor Cserni, Tamás Zombori, Xavier Andreu, et al.
Geburtshilfe Und Frauenheilkunde|January 18, 2019
Joint Guideline of the OEGGG, AGO, AGK and ÖGZ on the Diagnosis and Treatment of Cervical Intraepithelial Neoplasia and Appropriate Procedures When Cytological Specimens Are UnsatisfactoryOlaf Reich, Georg Braune, Wolfgang Eppel, et al.
Journal of Clinical Medicine|April 3, 2020
Local and Central Evaluation of HER2 Positivity and Clinical Outcome in Advanced Gastric and Gastroesophageal Cancer-Results from the AGMT GASTRIC-5 RegistryFlorian Huemer, Lukas Weiss, Peter Regitnig, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 2017
Quality indicators in breast cancer care: An update from the EUSOMA working groupLaura Biganzoli, Lorenza Marotti, Christopher D Hart, et al.
British Journal of Cancer|November 10, 2021
Sensitive and robust liquid biopsy-based detection of PIK3CA mutations in hormone-receptor-positive metastatic breast cancer patientsChristoph Suppan, Ricarda Graf, Stephan Jahn, et al.
European Journal of Cancer (Oxford, England : 1990)|August 12, 2008
Variations in sentinel node isolated tumour cells/micrometastasis and non-sentinel node involvement rates according to different interpretations of the TNM definitionsGábor Cserni, Simonetta Bianchi, Vania Vezzosi, et al.
Oncotarget|November 12, 2016
KCNJ3 is a new independent prognostic marker for estrogen receptor positive breast cancer patientsSarah Kammerer, Armin Sokolowski, Hubert Hackl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2010
Genomic index of sensitivity to endocrine therapy for breast cancerW Fraser Symmans, Christos Hatzis, Christos Sotiriou, et al.
Pathology Oncology Research : POR|July 17, 2012
Multi-institutional comparison of non-sentinel lymph node predictive tools in breast cancer patients with high predicted risk of further axillary metastasisGábor Cserni, Rita Bori, Róbert Maráz, et al.
Pageof 9

Showing results (61-70 of 89) with videos related to

Sort By:
Pageof 9
Frontiers in Psychology|August 8, 2022
Resilience and Protection of Health Care and Research Laboratory Workers During the SARS-CoV-2 Pandemic: Analysis and Case Study From an Austrian High Security LaboratoryMartina Loibner, Paul Barach, Stella Wolfgruber, et al.
Pathology Oncology Research : POR|April 10, 2017
Is Regression after Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer Different in Sentinel and Non-sentinel Nodes?Gábor Cserni, Tamás Zombori, Xavier Andreu, et al.
Geburtshilfe Und Frauenheilkunde|January 18, 2019
Joint Guideline of the OEGGG, AGO, AGK and ÖGZ on the Diagnosis and Treatment of Cervical Intraepithelial Neoplasia and Appropriate Procedures When Cytological Specimens Are UnsatisfactoryOlaf Reich, Georg Braune, Wolfgang Eppel, et al.
Journal of Clinical Medicine|April 3, 2020
Local and Central Evaluation of HER2 Positivity and Clinical Outcome in Advanced Gastric and Gastroesophageal Cancer-Results from the AGMT GASTRIC-5 RegistryFlorian Huemer, Lukas Weiss, Peter Regitnig, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 2017
Quality indicators in breast cancer care: An update from the EUSOMA working groupLaura Biganzoli, Lorenza Marotti, Christopher D Hart, et al.
British Journal of Cancer|November 10, 2021
Sensitive and robust liquid biopsy-based detection of PIK3CA mutations in hormone-receptor-positive metastatic breast cancer patientsChristoph Suppan, Ricarda Graf, Stephan Jahn, et al.
European Journal of Cancer (Oxford, England : 1990)|August 12, 2008
Variations in sentinel node isolated tumour cells/micrometastasis and non-sentinel node involvement rates according to different interpretations of the TNM definitionsGábor Cserni, Simonetta Bianchi, Vania Vezzosi, et al.
Oncotarget|November 12, 2016
KCNJ3 is a new independent prognostic marker for estrogen receptor positive breast cancer patientsSarah Kammerer, Armin Sokolowski, Hubert Hackl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2010
Genomic index of sensitivity to endocrine therapy for breast cancerW Fraser Symmans, Christos Hatzis, Christos Sotiriou, et al.
Pathology Oncology Research : POR|July 17, 2012
Multi-institutional comparison of non-sentinel lymph node predictive tools in breast cancer patients with high predicted risk of further axillary metastasisGábor Cserni, Rita Bori, Róbert Maráz, et al.
Pageof 9